City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers
Go back to City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers| Quest Diagnostics (NYSE: DGX) | Delayed: 197.18 +3.60 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.58 | 52 Week High | $86.85 | |||
| Open | $195.78 | 52 Week Low | $59.66 | |||
| Day High | $197.79 | P/E | 37.13 | |||
| Day Low | $194.15 | EPS | $5.31 | |||
| Volume | 1,009,601 | |||||
